Semax is a neuropeptide studied for cognition and neuroprotection. It is researched most often for Memory & focus, Neuroprotection and Stroke recovery studies. Primarily Russian clinical and preclinical research. This guide walks through what Semax is, how it's studied, what it's commonly combined with, and — just as important — where the science stops. It's educational information only, not medical advice.
What is Semax?
Semax is a synthetic peptide derived from a fragment of ACTH, developed in Russia and researched for cognitive enhancement and neuroprotection, including in the context of stroke recovery in regional clinical studies.
Also known as: ACTH 4-10 analog.
How does Semax work?
Semax is a synthetic peptide derived from a fragment of ACTH, developed in Russia and studied for cognitive and neuroprotective effects. Research points to influence on BDNF and other neurotrophic factors, and it has been used in regional clinical settings including stroke recovery.
What is Semax researched for?
In the research and community discussion, Semax comes up most often in connection with Memory & focus, Neuroprotection and Stroke recovery studies. Remember that "researched for" is not the same as "proven to treat" — these are the directions the science has explored, not established outcomes.
- Memory & focus
- Neuroprotection
- Stroke recovery studies
What does the research actually show?
Primarily Russian clinical and preclinical research. The honest framing matters here: promising mechanisms and early results are genuinely interesting, but they are not the same as proven, approved therapy. Anyone presenting Semax as a guaranteed treatment is getting ahead of the evidence.
What is Semax typically stacked with?
In the literature and community discussion, Semax is most often combined with Selank, based on complementary mechanisms. Selpho never provides dosing or protocols — combinations should only be considered with a licensed professional, since interactions and individual context matter.
Safety and considerations
Evidence is largely region-specific. Not an approved medication in the US/EU. Because the responsible framing is educational rather than prescriptive, Selpho provides no dosing, protocols, or purchase links, and always points back to a licensed professional for any decision. If you are dealing with a real health concern, that professional — not a peptide — is where planning should start.
Where to learn more about Semax
To go deeper, see the Semax library page for a quick reference; published research on PubMed; Selpho's free AI Peptide Advisor to see where Semax might fit your goals.
Frequently asked questions
Memory and focus, neuroprotection, and — in regional clinical studies — stroke recovery. Evidence is largely region-specific.
No. It is not an approved medication in the US or EU. Much of the clinical use and research is based in Russia.
They are often discussed together as Russian-developed neuropeptides, but Semax leans cognitive/neuroprotective while Selank leans anxiolytic.
Not sure if Semax fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis guide is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.